Delivery Order SPE2DB22D3016-SPE2DB24FBGG0
Award Date
9/9/24
Potential Completion Date
9/10/24
Potential Value
$290K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $9,586.99 Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT RABIES VACC W-DILUENTS. This award was made under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a $2,895.45 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide RABAVERT rabies vaccine with diluents. The order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp by DLA, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RABAVERT rabies vaccine with diluents. The award, valued at $35,517.52, has an ultimate completion date of April 1, 2024. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $2,895.45 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. This award falls under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, a $13,241.60 firm-fixed-price delivery order contract for RABAVERT rabies vaccine with diluents. This contract has a period of performance through July 25, 2024 and is not set aside for any specific business type. Amerisourcebergen, through its Corporate Office division, is a significant supplier of pharmaceutical products and medical supplies to various federal agencies and...
This is a $90,748.14 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccines with diluents. The delivery order has an ultimate completion date of May 29, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of RABAVERT rabies vaccine with diluents. The contract, valued at $5,790.90, has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $8,803.37 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of RABAVERT RABIES VACC W-DILUENTS, a rabies vaccine, with a performance period through May 14, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $4,951.07, is for the supply of RABAVERT rabies vaccine with diluents. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen with a potential value of $999,999,999.00 through December 31, 2025. This IDC...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract, valued at $5,790.90, has an ultimate completion date of October 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the agency to efficiently procure...